Still in favor of the therapeutic potential of O-GlcNAcylation in tauopathies, another group has developed an OGA-inhibiting molecule (LY3372689) [87] that is currently being evaluated in a phase 2 trial in humans because its safety profile was shown to be acceptable in phase 1 clinical studies [88]
Treatment with NR or the PARP inhibitor Olaparib also improved mitochondrial morphology in aged nematodes and mammalian muscle cells during proteotoxic stress 114
Now, this is where it gets interesting
Energy and Aging: By protecting the mitochondriathe powerhouses of your cellsit can help support overall energy levels and healthy cellular ageing
Nevertheless, compared with regenerative surgery using recombinant growth factors, stem cell therapy may bring economic concerns, as well as effort-related burdens
As every child is unique, a combined approach may be necessary to address their specific needs